Compare Bio Protocol (BIO) vs Neuron (NRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Neuron — how do they compare? Bio Protocol trades at Rp513.04 (market cap Rp1,15T, Rp260,42M 24h volume), while Neuron trades at Rp63.99 (market cap Rp26,48M, Rp841,43jt 24h volume). The key difference: Bio Protocol is far larger — about 43429× Neuron's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 358,6M / 1B NRN (36%) for Neuron. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Neuron for 10 Days on average.
| BIO | NRN | |
|---|---|---|
Market Cap | Rp1,15T | Rp26,48M |
Volume (24h) | Rp260,42M | Rp841,43jt |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 358,6M / 1B NRN (36%) |
Typical Hold Time | 16 Days | 10 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Neuron (NRN) is a low-market-cap cryptocurrency with a market cap of Rp26.48M and a circulating supply of 358,600 tokens out of a maximum 1 million, indicating a 36% circulation rate. The asset shows minimal trading activity and liquidity, with a short average hold time of 10 days suggesting speculative interest. No recent protocol upgrades or ecosystem developments are noted, and technical indicators are limited due to low volume.
Outlook: High-risk due to low liquidity and market cap, with potential for volatility. Opportunities include niche adoption if utility expands, but risks dominate—illiquidity, regulatory uncertainty, and lack of developer activity make it speculative. Investors should exercise caution and monitor for any network updates.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Neuron
NRN is developing an ecosystem aimed at accelerating the journey toward Artificial General Intelligence (AGI), using Gaming and robotics as experimental platforms. At its core is NRN Agents, a platform that facilitates the integration of AI agents within advanced Gaming experiences in both virtual and physical environments. The technology stack combines data aggregation, model training, and model inspection, utilizing both imitation learning and reinforcement learning to advance AI development.
Read more on NRN →
